Targeted drug delivery in pancreatic cancer

Xianjun Yu1, Yuqing Zhang, Changyi Chen

  • 1Michael E. DeBakey Department of Surgery, Molecular Surgeon Research Center, Elkins Pancreas Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.

Insights

Targeted drug delivery systems show promise for improving pancreatic cancer treatment outcomes. Developing specific, tumor-targeted methods is crucial due to resistance to conventional therapies.

Area of Science:

  • Oncology
  • Nanotechnology
  • Pharmacology

Background:

  • Pancreatic cancer exhibits high resistance to chemotherapy and radiation, leading to poor survival rates.
  • Current drug delivery methods face challenges in specificity and stability for effective pancreatic cancer treatment.

Purpose of the Study:

  • To review recent advancements in targeted drug delivery for pancreatic cancer.
  • To highlight potential therapeutic targets for improving treatment efficacy.

Main Methods:

  • Review of preclinical studies utilizing nanoparticles, liposomes, and carbon nanotubes for drug delivery.
  • Analysis of targeted delivery strategies using ligands and antibodies.

Main Results:

  • Nanoparticle-based systems have shown success in preclinical trials for delivering various therapeutic agents.
  • Improving specificity and stability of targeted delivery remains a key challenge.

Conclusions:

  • Novel, tumor-targeted drug delivery systems are urgently needed for pancreatic cancer.
  • Further research into ligand/antibody-directed delivery can enhance therapeutic outcomes.

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...